• Resources
  • Blog
  • Journalists
  • Webcasts
  • Data Privacy
  • Français
  • my CNW 
    • Login
    • Register
  • Client Login 
    • Online Member Centre
    • Next Gen Communications Cloud
    • Cision Communications Cloud®
  • Sign Up
  • Send a Release
Cision Canada
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
Advanced Search
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Canadian Federal Government
      • Canadian Municipal Government
      • Canadian Provincial Government
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

  • Advanced Search
  • Overview
  • Cision Communications Cloud®
  • Monitoring
  • Distribution
  • Multimedia
  • Guaranteed Paid Placement
  • Analytics
  • IR
  • Become a Client
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • General Enquiries
  • Media
  • Worldwide Offices
  • Cision Canada
  • Send a Release
  • FR
    • Phone

    • 877-269-7890 from 8 AM - 10 PM ET

    • ALL CONTACT INFO
    • Contact Cision

      877-269-7890
      from 8 AM - 10 PM ET

  • Send a Release
  • Sign Up
  • Resources
  • Blog
  • Journalists
  • Webcasts
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign Up
  • Resources
  • Blog
  • Journalists
  • Webcasts
  • GDPR
  • Overview
  • Cision Communications Cloud®
  • Monitoring
  • Distribution
  • Multimedia
  • Guaranteed Paid Placement
  • Analytics
  • IR
  • Send a Release
  • Sign Up
  • Resources
  • Blog
  • Journalists
  • Webcasts
  • GDPR
  • Become a Client
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • General Enquiries
  • Media
  • Worldwide Offices
  • Send a Release
  • Sign Up
  • Resources
  • Blog
  • Journalists
  • Webcasts
  • GDPR

An exceptional gift to support the CHU Sainte-Justine expertise and excellence in Sanfilippo disease research


News provided by

CHU Sainte-Justine Foundation

Nov 08, 2017, 14:43 ET

Share this article

Share this article


MONTRÉAL, Nov. 8, 2017 /CNW Telbec/ - Today the CHU Sainte-Justine celebrated the extraordinary commitment of $1 million from The Sanfilippo Children's Research Foundation (SCRF) and the Linton family to support research on Sanfilippo disease, a rare neurodegenerative disease for which there is currently no cure. The CHU Sainte-Justine Foundation is deeply moved by the Toronto-area family's gesture of incredible generosity and solidarity. This donation will allow the creation of The Sanfilippo Children's Research Endowment Fund, which will ensure the sustainability of research on this disease. A powerful gesture all the more meaningful for Elisabeth and Randall Linton, founders of the SCRF, as it honours the memory of their youngest daughter Elisa, whose life was claimed by the disease at the age of 22, on October 31, 2016.

Front row: Jacynthe Côté, Pr Alexey V. Pshezhetsky, Elisabeth Linton and Maud Cohen; Back row: Dr Fabrice Brunet, Randall Linton, Connor Linton, Jessica Linton and Dr. Jacques L. Michaud (CNW Group/CHU Sainte-Justine Foundation)
Front row: Jacynthe Côté, Pr Alexey V. Pshezhetsky, Elisabeth Linton and Maud Cohen; Back row: Dr Fabrice Brunet, Randall Linton, Connor Linton, Jessica Linton and Dr. Jacques L. Michaud (CNW Group/CHU Sainte-Justine Foundation)

"Our family is thrilled that this donation, made possible by the many people who financially supported The Sanfilippo Children's Research Foundation and whose hearts were inspired by our daughter Elisa, will advance the ground-breaking research at the CHU Sainte-Justine here in Canada. It's too late for Elisa, but we're in a race against time battling this disease. We know that other children and their families will benefit from future advances in research", said Mrs. Elisabeth Linton, Executive Director of The SCRF, accompanied by her husband, Randall, and their children, Jessica and Connor.

The SCRF and the Linton family see this gift as a loving tribute to their daughter, and a symbol of hope for the children and families struggling with this devastating disease. Few children survive beyond the first fifteen years of life. Elisa miraculously lived until she was 22 years old.

This hope could soon become reality, thanks to Professor Alexey V. Pshezhetsky, researcher with the Metabolic Health and Complex Diseases Research Axis at the CHU Sainte-Justine's Research Centre, who was chosen by the SCRF and the Linton family for his exceptional scientific career. Over the years, his research has been recognized by several national and international organizations. His contributions to the field of human genetics have earned him many awards and grants. Professor Pshezhetsky is also one of the few, and best, researchers in the world to devote significant research to Sanfilippo disease. In 2006, he and his team identified one of the genetic causes of the disease named Sanfilippo type C.

"Sanfilippo disease is a mucopolysaccharide disorder type III (MPS-III), a disease that affects the lysosome, the cell compartment responsible for the breakdown and recycling of molecules. It causes progressive neurodegeneration in infants and children, leading to mental impairment and often to death between the ages of 10 and 20," explained Professor Pshezhetsky. "This donation will significantly accelerate the development of therapy for serious childhood diseases, like MPS III, and will pave the way for a cure for other pediatric neurodegenerative disorders caused by protein defects."

To mark The SCRF's extraordinary support and to honour the memory of Elisa Linton, the laboratory headed by Professor Pshezhetsky will be named The Elisa Linton Sanfilippo Research Laboratory.

"Supported by international collaboration with various experts and pan-Canadian scientific cooperation, the laboratory's multidisciplinary team is a testament to the importance of creating a health research consortium. This approach will ensure the sustainability of research into Sanfilippo disease and lead to important breakthroughs that will save lives. I am very pleased to have the commitment of the Sanfilippo Children's Research Foundation and the Linton family, as it shows their confidence in the excellence and expertise of our researchers. It is a confidence that once again demonstrates our institution's research leadership on rare diseases," said Dr. Fabrice Brunet, CEO of the CHUM-CHU Sainte-Justine.

"The CHU Sainte-Justine Foundation is honoured to welcome The Sanfilippo Children's Research Foundation and the Linton family as one of the major donors to the Healing More Better campaign. I would like to thank them very much. It is with great pride that we recognize their invaluable contribution, which will allow the CHU Sainte-Justine's researchers to make major advances in the development of curative treatments for Sanfilippo disease. But most importantly, they are offering children and families affected by this disease hope for a better quality of life and the dream of a cure," said Mrs. Maud Cohen, President and CEO of the CHU Sainte-Justine Foundation.

Thank you, from the bottom of our hearts, to the Sanfilippo Children's Research Foundation and the Linton family for their exceptional support and their gesture of generosity, affection and unwavering solidarity towards children and families affected by Sanfilippo disease.

About the CHU Sainte-Justine Foundation
The CHU Sainte-Justine Foundation's mission is to engage the community and support the CHU Sainte-Justine in its pursuit of excellence and its commitment to providing children and mothers with one of the highest levels of healthcare in the world, now and in the future. fondation-sainte-justine.org/en/

About the CHU Sainte-Justine
The Sainte-Justine university hospital centre (CHU Sainte-Justine) is the largest mother-child centre in Canada and the second largest pediatric hospital in North America. A member of the Université de Montréal extended network of excellence in health (RUIS), Sainte-Justine has 5,664 employees, including 1,578 nurses and nursing assistants; 1,117 other healthcare professionals; 502 physicians, dentists and pharmacists; 822 residents  and over 200 researchers; 300 volunteers; and 3,400 interns and students in a wide range of disciplines. Sainte-Justine has 484 beds, including 35 at the Centre de réadaptation Marie Enfant (CRME), the only exclusively pediatric rehabilitation centre in Quebec. The World Health Organization has recognized CHU Sainte-Justine as a "health promoting hospital." chusj.org

About the Sanfilippo Children's Research Foundation
In 1999, with faith and determination, we, Elisabeth and Randall Linton, formed The Sanfilippo Children's Research Foundation (SCRF) right after our youngest daughter, Elisa, was diagnosed with the Sanfilippo disease. Our goal is to fund medical research to find a cure for Sanfilippo and its related neuro-genetic disorders. We are the only foundation in Canada raising funds for Sanfilippo research. In almost 18 years, over $7.5M has been raised with a remarkable 96% of every dollar donated being committed to research. More than 35 research projects have been initiated worldwide due to the efforts of The SCRF. While Sanfilippo occurs once in 24,000 births, successful research into the disease could apply directly to related genetic conditions that affect 1 child in 5,000. Elisa lived to the miraculous age of 22 but Sanfilippo disease sadly claimed her life on October 31, 2016. alifeforelisa.org  

SOURCE CHU Sainte-Justine Foundation

For further information: CHU Sainte-Justine Foundation, Delphine Brodeur, Director, Communication, Public Relations and Donor Relations, 514 345-4931, ext. 4356, [email protected]

Related Links

www.fondation-sainte-justine.org/fr/

Modal title

Organization Profile

CHU Sainte-Justine Foundation

    Also from this source

  • CHU Sainte-Justine Foundation receives biggest-ever donation to a Quebec hospital

  • /R E P E A T -- MEDIA ADVISORY - Pediatric research - CHU Sainte-Justine Foundation set to announce biggest-ever donation to a Quebec hospital/

  • /R E P E A T -- MEDIA ADVISORY - Pediatric research - CHU Sainte-Justine Foundation set to announce biggest-ever donation to a Quebec hospital/

Contact Cision

  • 877-269-7890
    from 8 AM - 10 PM ET

  • Become a Client
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • General Enquiries
  • Media
  • Worldwide Offices

Products

  • Cision Communications Cloud®
  • Media Monitoring
  • Content Distribution
  • Multimedia Distribution
  • Measurement & Analytics
  • Investor Relations

About

  • About Cision Canada
  • About Cision
  • Media Partners
  • Careers
  • Accessibility Statement

My Services

  • All News Releases
  • Online Member Centre
  • Next Gen Communications Cloud
  • Cision Communications Cloud®
  • my CNW

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Centre
  • Next Gen Communications Cloud
  • Cision Communications Cloud
  • my CNW
877-269-7890
from 8 AM - 10 PM ET
  • Terms of Use
  • Information Security Policy
  • Site Map
  • Cookie Settings
  • Accessibility Statement
Copyright © 2023 CNW Group Ltd. All Rights Reserved. A Cision company.